Australia, Aug. 29 -- Abiologics Inc., owns the trademark (2491996) for 'SYNTEIN' till April 29, 2034.
Status: protected:
Registered/protected
Classes: 1 [Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research.], 5 [Synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in...